NeoNeuro has been granted support from BPIfrance Financement under the PIA-1 program for the use of aptamers as a diagnostic and therapeutic tools in Alzheimer’s disease.
NeoNeuro has been granted support from BPIfrance Financement under the PIA-1 program for the use of aptamers as a diagnostic and therapeutic tools in Alzheimer’s disease.